FP
Ferndale Pharmaceuticals Ltd
Ferndale Pharmaceuticals Ltd is a UK limited company, based in Wetherby, incorporated in 2003. Has won 6 UK public-sector contracts worth £35.8m across 2 buyers, primarily NHS England.
Active contracts
4
no new awards in 30d
Contracted (12m)
—
no data
Public buyers
2
stable this month
Top buyer share
100%
NHS England
Risk signals · 1 active
Derived from Companies House filings. More sources (HMRC, Insolvency Service register, press) will be added incrementally.
Confirmation statement overdue
Statement was due 22 Apr 2026 — required annually under s.853A CA 2006.
MEDIUM
Buyer concentration
Each block sized by share of total award value. A dominant block signals dependency on one buyer.
Severe concentration. Top buyer alone = 100% of revenue.
NHS England
£35.8m
100%The NHS Commissioning Board (operating under the name of NHS England)
—
0%Contracts won · 6 total · 4 active · 2 expired
Every contract award published under the Procurement Act.
| Title | Buyer | Award type | Value | Awarded | Status |
|---|---|---|---|---|---|
| NHS Framework Agreement for Branded Medicines - National | NHS England | Shared contract | £18.5m lot total · 73 suppliers | 01 May 2019 | expired |
| NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 | NHS England | Shared contract | £11.2m lot total · 90 suppliers | 05 Apr 2024 | active |
| NHS Framework Agreement for Branded medicines - National | NHS England | Framework call off | £6.1m ceiling · ~£71k share (÷86) | 16 May 2022 | expired |
| NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 | NHS England | Direct contract | — | — | active |
| NHS Framework Agreement for Branded Medicines - National Tender | NHS England | Direct contract | — | — | active |
| NHS National Generic Pharmaceuticals Wave 13 | The NHS Commissioning Board (operating under the name of NHS England) | Direct contract | — | — | active |